Overview
Eric Morel practices practicing medicine in Paris, France.
His clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy and Cardiomyopathy Due to Anthracyclines.
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Eric Morel
Is Eric Morel a top-rated expert for Doxorubicin-Induced Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Eric Morel is classified as an Experienced expert for Doxorubicin-Induced Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Eric Morel participate in research or clinical trials?
Yes. Eric Morel has published 14 articles and abstracts on conditions like Doxorubicin-Induced Cardiomyopathy. You can view a list of Eric Morel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cardiomyopathy Due to AnthracyclinesMr. Morel isExperienced. Learn about Cardiomyopathy Due to Anthracyclines.
- Doxorubicin-Induced CardiomyopathyMr. Morel isExperienced. Learn about Doxorubicin-Induced Cardiomyopathy.